Literature DB >> 19505276

Management of nocturnal hypertension.

Rajiv Vij1, Aldo J Peixoto.   

Abstract

Nocturnal hypertension is a common complication of essential and secondary hypertension. Abnormal circadian blood pressure patterns associated with elevated sleep blood pressure include nondipping and reverse dipping, both of which are associated with increased target-organ damage and adverse cardiovascular outcomes. Nocturnal hypertension can be treated with several approaches that include both lifestyle changes, such as sodium restriction and potassium supplementation, and pharmacological treatments, primarily through the use of bedtime dosing of antihypertensive agents. Evening administration of blockers of the renin-angiotensin-aldosterone system is the most consistently effective of these treatment strategies. In this review, we provide a detailed discussion of the options available for the management of nocturnal hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505276     DOI: 10.1586/erc.09.42

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  6 in total

Review 1.  Role of circadian rhythms in potassium homeostasis.

Authors:  Michelle L Gumz; Lawrence Rabinowitz
Journal:  Semin Nephrol       Date:  2013-05       Impact factor: 5.299

2.  Race and sex differences in asleep blood pressure: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  John N Booth; D Edmund Anstey; Natalie A Bello; Byron C Jaeger; Daniel N Pugliese; Stephen Justin Thomas; Luqin Deng; James M Shikany; Donald Lloyd-Jones; Joseph E Schwartz; Cora E Lewis; Daichi Shimbo; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-05       Impact factor: 3.738

3.  Implantable impedance plethysmography.

Authors:  Michael Theodor; Dominic Ruh; Martin Ocker; Dominik Spether; Katharina Förster; Claudia Heilmann; Friedhelm Beyersdorf; Yiannos Manoli; Hans Zappe; Andreas Seifert
Journal:  Sensors (Basel)       Date:  2014-08-13       Impact factor: 3.576

Review 4.  The dilemma of nocturnal blood pressure.

Authors:  Tan Xu; Yong-Qing Zhang; Xue-Rui Tan
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-09-12       Impact factor: 3.738

5.  Using Predicted Atherosclerotic Cardiovascular Disease Risk for Discrimination of Awake or Nocturnal Hypertension.

Authors:  Swati Sakhuja; John N Booth; David E Anstey; Byron C Jaeger; Cora E Lewis; Donald M Lloyd-Jones; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Paul Muntner
Journal:  Am J Hypertens       Date:  2020-11-03       Impact factor: 3.080

6.  Nocturnal hypertension in primary care patients with high office blood pressure: A regional study of the MAPAGE project.

Authors:  Claire Zabawa; Clément Charra; Anne Waldner; Gilles Morel; Marianne Zeller; Adrien Guilloteau; Katia Mazalovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-08       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.